ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PHIO Phio Pharmaceuticals Corporation

0.88
0.1043 (13.45%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Phio Pharmaceuticals Corporation PHIO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.1043 13.45% 0.88 18:59:58
Open Price Low Price High Price Close Price Previous Close
0.81 0.7762 0.8299 0.8197 0.7757
more quote information »

Recent News

Date Time Source Heading
4/30/202406:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
4/22/202412:10GLOBEIntratumoral Injection of Phio’s PH-762 significantly..
4/16/202406:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentations at the..
4/11/202406:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
4/03/202406:30GLOBENational Spotlight Features Phio’s Innovative RNAi..
4/02/202406:30GLOBEPhio Pharmaceuticals Reports 2023 Year End Financial Results..
3/21/202406:30GLOBEPhio Pharmaceuticals Presenting Data Showing INTASYL May..
3/13/202413:00GLOBEPhio Pharmaceuticals Announces Addition of Clinical Trial..
3/06/202409:30GLOBEPhio Pharmaceuticals Announces Patent Granted by USPTO,..
3/05/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202409:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202407:00GLOBEPhio Pharmaceuticals Announces Data Showing INTASYL May..
1/26/202416:00EDGAR2Form 8-K - Current report
12/28/202308:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/27/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
12/19/202315:52EDGAR2Form S-1 - General form for registration of securities under..
12/08/202316:00EDGAR2Form 8-K - Current report
12/07/202307:00GLOBEPhio Pharmaceuticals Announces Exercise of Warrants for $2.8..
11/09/202315:40EDGAR2Form 8-K - Current report
11/09/202315:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:30GLOBEPhio Pharmaceuticals Reports Third Quarter 2023 Financial..
11/09/202306:30GLOBEPhio Pharmaceuticals Announces First US Patient Enrolled in..
11/03/202311:00GLOBEPhio Pharmaceuticals Presents New Data Showing INTASYL..
10/12/202310:00GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
10/11/202306:30GLOBEPhio Pharmaceuticals Presents New Data for Targeting of BRD4..
9/06/202306:30GLOBEPhio CEO to Speak at Wainwright Conference in New York in..
8/21/202306:30GLOBEPhio Pharmaceuticals Announces Dosing of First Patient in..
8/21/202306:30EDGAR2Form 8-K - Current report
8/10/202315:40EDGAR2Form 8-K - Current report
8/10/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202315:30GLOBEPhio Pharmaceuticals Reports Second Quarter 2023 Financial..
7/26/202315:30EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock